![Michael Holdbrook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Holdbrook
Inga fler pågående positioner
Profil
Michael Holdbrook worked as a Senior Director-Clinical Affairs & Biostatistics at Oculeve, Inc. from 2014 to 2017.
He then served as a Vice President at Experien Group LLC.
In 2018, he joined Tarsus Pharmaceuticals, Inc. as a Senior Vice President-Clinical Affairs, where he worked until 2023.
Mr. Holdbrook completed his undergraduate degree at the University of California San Diego.
Tidigare kända positioner av Michael Holdbrook
| Företag | Position | Slut |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-04-01 |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Företagsledare/Principal | 2017-10-01 |
Experien Group LLC
 Experien Group LLC Miscellaneous Commercial ServicesCommercial Services Provides regulatory, quality and clinical consulting services | Företagsledare/Principal | - |
Michael Holdbrooks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
24
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Experien Group LLC
Experien Group LLC Miscellaneous Commercial ServicesCommercial Services Provides regulatory, quality and clinical consulting services | Commercial Services |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
